SGD Pharma is a global leader in glass pharmaceutical packaging. SGD Pharma produces over 8 million vials and bottles per day at its five manufacturing plants in Europe and Asia. All plants are ISO 15378 certified, and two are entirely new facilities.

SGD Pharma has a history. Here's what you need to know about our governance, key facts and key milestones.

作为持续改进项目的一部分，2020年 SGD Pharma 法国圣康坦拉莫特（Saint-Quentin-Lamotte）工厂 对透明一类玻璃进行了成分升级。该项目也升级了生产工艺，提高了玻璃瓶质量的稳定性及耐化学性，可减少与敏感药物配方的相互作用以满足更严格的法规要求。

SGD Pharma 在欧洲和亚洲共有五个工厂，每天生产超过8百万支玻璃瓶。 所有工厂均通过 ISO 15378 认证，其中两家工厂配备全新设施。 SGD Pharma 在全球设有9个销售办事处，并拥有一个非常广泛的分销网络，提供各种一类、二类或三类玻璃包装产品、棕色和透明玻璃以及如内部硅化或塑料防护涂层等创新型增值服务。 联系我们. 为客户提供高品质、可信赖、创新型医药玻璃 …

CEO Olivier Rousseau explains that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its commercial, innovation, industrial, sustainability, HR and M&A strategies.

SGD Pharma has more than 100 years of experience in the production of pharmaceutical glass primary packaging. The company offers aerosol bottles, jars, decanters, injectable vials and other products, enabling companies to get a broad range of products with customization options.

Feb 7, 2025 · The coveted platinum rating means that SGD Pharma is now placed in the top 1 percent of glass manufacturers in the world. Having received a score of 87/100 (the company’s highest ever rating), SGD Pharma improved its individual scores across every evaluated area to achieve an “outstanding” rating in almost all categories.

Mar 19, 2025 · France-based SGD Pharma is using its presence at the Drug, Chemical & Associated Technologies Association (DCAT) Week 2025 to demonstrate how its multi-million-Euro investments in the next generation of glass manufacturing are impacting sustainability and innovation in the pharmaceutical industry (1).

SGD Pharma is a network of five industry-reference plants located in France, Germany, China, and India. It supplies Type I, II, and III, molded and tubular, amber, and flint glass packaging to a wide range of customers including international pharma laboratories, generics manufacturers, CDMOs, biotechs, and wholesalers.

Jun 22, 2021 · PAI Partners (“PAI”), a leading European private equity firm, announced that it has made a binding offer for the acquisition of SGD Pharma (the “Company”), a leading global manufacturer of primary glass packaging for the pharmaceutical industry, to China Jianyin Investment Ltd. (“JIC”)